[1]
Gheorghe, L., Preda, C., Trifan, A., Manuc, M., Stanciu, C., Istratescu, D., Popescu, C., Diculescu, M., Tieranu, C., Manuc, T., Stroie, T., Iacob, S. and Iliescu, L. 2022. Real World Efficacy and Safety of Sofosbuvir + Velpatasvir + Voxilaprevir in Romanian Patients with Genotype 1b HCV Infection Non-reponders to DAAs Therapy. Journal of Gastrointestinal and Liver Diseases. 31, 4 (Dec. 2022), 437-443. DOI:https://doi.org/10.15403/jgld-4472.